CABAS, NICOLA
CABAS, NICOLA
DMED - DIPARTIMENTO DI MEDICINA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.007 secondi).
Efficacy and safety of apremilast in a patient with paraneoplastic dermatomyositis with resistant skin disease
2023-01-01 Cabas, N.; Turina, M.; Pizzolitto, S.; De Vita, S.; Quartuccio, L.
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients
2022-01-01 Fabris, M.; De Marchi, G.; Domenis, R.; Caponnetto, F.; Guella, S.; Dal Secco, C.; Cabas, N.; De Vita, S.; Beltrami, A. P.; Curcio, F.; Quartuccio, L.
Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab
2023-01-01 Quartuccio, L.; De Marchi, G.; Domenis, R.; Cabas, N.; Guella, S.; Paradiso, A.; Fabro, C.; Beltrami, A. P.; De Vita, S.; Curcio, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Efficacy and safety of apremilast in a patient with paraneoplastic dermatomyositis with resistant skin disease | 1-gen-2023 | Cabas, N.; Turina, M.; Pizzolitto, S.; De Vita, S.; Quartuccio, L. | |
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients | 1-gen-2022 | Fabris, M.; De Marchi, G.; Domenis, R.; Caponnetto, F.; Guella, S.; Dal Secco, C.; Cabas, N.; De Vita, S.; Beltrami, A. P.; Curcio, F.; Quartuccio, L. | |
Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab | 1-gen-2023 | Quartuccio, L.; De Marchi, G.; Domenis, R.; Cabas, N.; Guella, S.; Paradiso, A.; Fabro, C.; Beltrami, A. P.; De Vita, S.; Curcio, F. |